Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings

Sun Pharmaceutical Industries has announced the 100 per cent sale of its step-down subsidiary, Sun Pharma Japan Technical Operations, to Zaza Industrial Holdings K.K., Japan.
The decision marks a strategic move by the company, which operates one of the largest pharmaceutical businesses globally.
According to a regulatory filing with BSE, the agreement was signed on December 31, 2024, with transaction expected to be completed by January 31, 2025.
The turnover of Sun Pharma Japan Technical Operations Limited contributed less than 0.5 per cent to Sun Pharma’s consolidated turnover in the financial year 2023-24. The subsidiary has been sold for a nominal consideration of JPY 1 (Japanese Yen One only).
The subsidiary operates a manufacturing plant in Saitama, Japan, which produces products for Sun Pharma Japan. The plant will continue to supply products to Sun Pharma under a contract valid till May 2026.

 

The buyer, Zaza Industrial Holdings K.K., is a Japan-based company with no affiliation to Sun Pharma’s promoter group.

 

Sun Pharma, one of India’s largest pharmaceutical companies, has been taking measures to streamline its operations and focus on core markets. The move to divest the subsidiary aligns with the company’s broader strategy to optimise its global operations.

Related Posts

  • Pharma
  • July 15, 2025
  • 96 views
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

  • Pharma
  • July 15, 2025
  • 104 views
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR